Verano Q4 revenue $237M (+5% YoY); FY2023 adj. EBITDA $305M; guides Q1 down 5-7%

Verano Holdings Corp.

2023-FY EPS reported -$0.34 revenue$938,452,000

Q4 2023 revenue $237M (+5% YoY); net loss $72.6M; adjusted EBITDA $73.4M (31% margin).
Full-year 2023 revenue $938M (+7% YoY); net loss $112.7M; net cash from operations $110M (+16% YoY).
Q1 2024 revenue guidance: 5-7% decline vs prior year; cites dispensary count normalization in New Jersey.
Balance sheet: cash $175M; total debt net $446M; opened 3 new MÜV dispensaries in Florida and 2 Zen Leaf in Pennsylvania.
Retail footprint now 138 dispensaries across 13 states; 14 production facilities with >1M sq ft cultivation.

item 2.02 item 2.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.75

Verano Holdings Corp. reported financial results for the fourth quarter and year ended December 31, 2023.

Period: the fourth quarter and year ended December 31, 2023
Result: reported results

Exact text from the filing

On February 29, 2024, Verano Holdings Corp. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

Verano Holdings Corp. filing history →

Source: SEC EDGAR

accession 0001628280-24-007785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.